Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.460
+0.004 (0.79%)
Feb 12, 2025, 4:18 PM EST - Market closed
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $19.21 million as of February 12, 2025. Its market cap has decreased by -77.87% in one year.
Market Cap
19.21M
Enterprise Value
-5.60M
1-Year Change
-77.87%
Ranking
Category
Stock Price
$0.46
Market Cap Chart
Since February 6, 2014, Carisma Therapeutics's market cap has decreased from $159.40M to $19.21M, a decrease of -87.95%. That is a compound annual growth rate of -17.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2025 | 19.10M | 9.14% |
| Dec 31, 2024 | 17.50M | -85.19% |
| Dec 29, 2023 | 118.20M | -4.37% |
| Dec 30, 2022 | 123.60M | -23.99% |
| Dec 31, 2021 | 162.60M | -6.87% |
| Dec 31, 2020 | 174.60M | 60.33% |
| Dec 31, 2019 | 108.90M | -1.00% |
| Dec 31, 2018 | 110.00M | 326.36% |
| Dec 29, 2017 | 25.80M | -44.28% |
| Dec 30, 2016 | 46.30M | -21.53% |
| Dec 31, 2015 | 59.00M | -69.51% |
| Dec 31, 2014 | 193.50M | 21.39% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 786.05B |
| UnitedHealth Group | 485.36B |
| Johnson & Johnson | 373.81B |
| Novo Nordisk | 361.12B |
| AbbVie | 341.06B |
| AstraZeneca | 227.13B |
| Abbott Laboratories | 226.33B |
| Merck & Co. | 216.71B |